Greater China
MBK exits China's Apex International
MBK Partners has agreed to sell Apex International, China’s second-largest air freight forwarder, to Swiss logistics giant Kuehne + Nagel.
CPE leads $300m round for China's ANE Logistics
ANE Logistics, one of China’s top three less-than-truckload (LTL) logistics players, has raised $300 million in funding led by CPE. Greater Bay Area Fund, Hong Kong-listed NWS Holdings, Liumai Capital, and Huagai Capital also took part.
Temasek backs China industrial SaaS player
Temasek Holdings has led a RMB500 million ($77 million) round for Black Lake Technologies, a China-based software-as-a-service (SaaS) provider for manufacturers.
CPE leads $123m round for China's Wangjiahuan
Shenzhen-based agricultural products distributor Wangjiahuan has raised RMB800 million ($123 million) in a Series B extension led by CPE.
China's Regor Therapeutics raises $90m Series B
Lilly Asia Ventures (LAV) has led a $90 million Series B round for Regor Therapeutics, a Chinese drug developer specializing in bioinformatics.
China self-driving truck player Plus raises $200m
Plus, a China-based autonomous driving technology developer that specializes in trucks, has completed a $200 million round of funding led by Guotai Junan International, CPE, and automotive partssupplier Wanxiang.
China cancer screening business gains on Hong Kong debut
New Horizon Health, a China-based and venture capital-backed cancer early screening company, rose 215% on its trading debut following a HK$2 billion ($258 million) Hong Kong IPO.
China's CITIC sells US dental business
CITIC Capital Partners has exited US-based dental business DDS Lab – the private equity firm’s first acquisition in the US as a lead investor – to RoundTable Healthcare Partners for an undisclosed sum.
PE-backed JD Logistics set for Hong Kong listing
JD Logistics, a supply chain solutions and logistics provider that spun-out from Chinese online retailer JD.com, has filed for a Hong Kong IPO. The company has received $2.57 billion in private funding.
Chinese virotherapy specialist Binhui Biotech raises $93m
Wuhan-based Binhui Biotech has raised RMB600 million ($93 million) in Series C funding led by Shenzhen-based Share Capital. Other investors include CICC Capital, Vertex Ventures China and Qianhai FOF under Shenzhen Capital Group.
Q&A: Gushcloud's Althea Lim
Singapore’s Gushcloud, a VC-backed influencer talent agency and content producer, operates at the frontlines of a young, fast-changing media landscape. CEO Althea Lim tours the latest developments
China teahouse chain Nayuki pursues Hong Kong IPO
Nayuki, a private equity-backed Chinese teahouse chain also known as Naixuecha, has filed for a Hong Kong IPO. It comes on the heels of a $100 million Series C round.
Deal focus: Asia Green Fund secures DuPont carve-out
Asia Green Fund reunited with the team at special situations investor BroadPeak Global for the $510 million acquisition of DuPont's clean energy unit. Driving expansion in China is now the priority
Asia to play larger role in Eurazeo's second smart city fund
Asia is expected to feature more prominently – in terms of investors and investments – in Eurazeo’s second smart city venture capital fund, which has reached a first close of EUR80 million ($97 million).
Deal focus: CPE backs MicroPort's medical devices agenda
CPE has backed a string of spinouts from Chinese medical device manufacturer MicroPort Medical. MicroPort CardioFlow Medtech’s Hong Kong IPO represents its first liquidity event
China's Cloopen, Adagene complete strong US IPOs
Cloud services provider Cloopen and biotech developer Adagene, both backed by Sequoia Capital China, have raised a combined $460 million in their US IPOs.
China EV maker WM Motor gets $1.7b in debt financing
Chinese electric vehicle (EV) manufacturer WM Motor has secured RMB11.5 billion ($1.78 billion) in debt from domestic banks. It follows a RMB10 billion equity funding round featuring several government investors.
New Frontier to privatize US-listed China hospital business
The New Frontier Group-led consortium that acquired Chinese hospital operator United Family Healthcare (UFH) through a special purpose acquisition company (SPAC) in 2019 is now looking to take the US-listed business private at a valuation of around $1.6...
Cathay appoints executive president, makes partner promotions
Cathay Capital has announced a spate of global personnel appointments in private equity and venture capital, including the naming of Arthur Yeung as executive president.
China's Meishubao gets $40m Series D extension
Meishubao, a China-based online art education platform, has completed a Series D extension of more than $40 million that takes the overall funding round past $250 million.
Ethics in AI: Slippery slope
Concerns around artificial intelligence technology have extended from unauthorized surveillance to include healthcare and education. When does the ethical dilemma become an ESG sticking point for investors?
Sequoia, Tencent lead Series E for China's Miaoshou Doctor
Beijing Yuanxin Technology, operator of China-based online healthcare services platform Miaoshou Doctor, has raised RMB3 billion ($466 million) in Series E funding led by Sequoia Capital China and Tencent Holdings.
Eastern Bell seeks $600m for second US dollar fund
Eastern Bell Capital, a Chinese private equity firm that focuses on supply chains and logistics businesses, has set a target of $600 million for its second US dollar-denominated fund.
China's Yunqi promotes Yu Chen to partner
Chinese venture capital firm Yunqi Partners has promoted Yu Chen - who specializes in big data, cloud computing, autonomous driving, and robotics investments - to partner.